The Future of Precision Medicine: Potential Impacts for Health Technology Assessment J Love-Koh, A Peel, JC Rejon-Parrilla, K Ennis, R Lovett, A Manca, ... PharmacoEconomics, 1-13, 2018 | 114 | 2018 |
The EQ Health and Wellbeing: overview of the development of a measure of health and wellbeing and key results J Brazier, T Peasgood, C Mukuria, O Marten, S Kreimeier, N Luo, ... Value in Health, 2022 | 62 | 2022 |
Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE–MD (Coordinating Research and Evidence for Medical Devices) AG Fraser, RGHH Nelissen, P Kjærsgaard-Andersen, P Szymański, ... EFORT open reviews 6 (10), 839-849, 2021 | 35 | 2021 |
Obstructive sleep apnoea health economics report JC Rejón-Parrilla, M Garau, J Sussex London: British Lung Foundation, Office for Health Economics, 2014 | 30 | 2014 |
The use of non-randomised evidence to estimate treatment effects in health technology assessment S Kent, M Salcher-Konrad, S Boccia, J Bouvy, C de Waure, J Espin, ... Journal of Comparative Effectiveness Research, 2021 | 27 | 2021 |
What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years … T Peasgood, C Mukuria, J Carlton, J Connell, N Devlin, K Jones, R Lovett, ... The European Journal of Health Economics, 1-15, 2021 | 23 | 2021 |
How innovation can be defined, evaluated and rewarded in health technology assessment JC Rejon-Parrilla, J Espin, D Epstein Health economics review 12 (1), 1-11, 2022 | 16 | 2022 |
Use of Expert Judgement Across NICE Guidance-Making Programmes: A Review of Current Processes and Suitability of Existing Tools to Support the Use of Expert Elicitation A Peel, M Jenks, M Choudhury, R Lovett, JC Rejon-Parrilla, A Sims, ... Applied health economics and health policy 16 (6), 819-836, 2018 | 14 | 2018 |
Supporting professional nurse socialisation: Findings from evidence reviews JC Rejon, C Watts Royal College of Nursing (RCN): https://www.researchgate.net/profile …, 2014 | 14 | 2014 |
Using HTA and guideline development as a tool for research priority setting the NICE way: reducing research waste by identifying the right research to fund. T Sharma, M Choudhury, JC Rejón-Parrilla, P Jonsson, S Garner BMJ open 8 (3), e019777, 2018 | 9 | 2018 |
The expanding value footprint of oncology treatments JC Rejón-Parrilla, K Hernández-Villafuerte, K Shah, J Mestre-Ferrandiz, ... London: Office of Health Economics, 2014 | 8 | 2014 |
Economic evaluation of the use of a pharmacogenetic diagnostic test in schizophrenia JC Rejon-Parrilla, M Nuijten, WK Redekop, JG Gaultney Health Policy and Technology 3 (4), 314-324, 2014 | 7 | 2014 |
Correction to: The Future of Precision Medicine: Potential Impacts for Health Technology Assessment J Love-Koh, A Peel, JC Rejon-Parrilla, K Ennis, R Lovett, A Manca, ... Pharmacoeconomics 37, 117-117, 2019 | 3 | 2019 |
Pricing and Reimbursement Mechanisms for Advanced Therapy Medicinal Products in 20 countries JC Rejon-Parrilla, J Espin, S Garner, S Kniazkov, D Epstein Frontiers in Pharmacology 14, 1199500, 2023 | 1 | 2023 |
Key enablers and barriers to implementing adaptive pathways in the European setting. JC Rejon-Parrilla, P Jonsson, JC Bouvy British journal of clinical pharmacology, 2019 | 1 | 2019 |
Correction to: Use of Expert Judgement Across NICE Guidance‑Making Programmes: A Review of Current Processes and Suitability of Existing Tools to Support the Use of Expert … A Peel, M Jenks, M Choudhury, R Lovett, JC Rejon‑Parrilla, A Sims, ... Applied Health Economics and Health Policy 17 (2), 263, 2019 | 1 | 2019 |
The Future of Precision Medicine: What Does it Mean for Nice? JC Rejon-Parrilla, RE Lovett, A Chalkidou, J Love-Koh, H Wood, K Ennis, ... Value in Health 20 (9), A404, 2017 | | 2017 |
Complementary Diagnostics: A Literature Review on the Value of Knowing B Zamora, J Mestre-Ferrandiz, JC Rejon-Parrilla, L Garrison OHE Research paper: http://www.ohe.org/sites/default/files …, 2016 | | 2016 |